You are here

  • Home
  • Archive
  • Volume 6, Issue 12
  • Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol

Article info

Article menu

Download PDFPDF

XML
Rheumatology
Protocol
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol

Authors

  • Alicia Calderone Department of Rheumatology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Wendy Stevens Department of Rheumatology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • David Prior Department of Cardiology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia The University of Melbourne Department of Medicine at St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Harshal Nandurkar The University of Melbourne Department of Medicine at St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Eli Gabbay The University of Notre Dame, Fremantle, Western Australia, Australia Institute for Respiratory Health, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Susanna M Proudman Department of Rheumatology, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia University of Adelaide Discipline of Medicine at Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia PubMed articlesGoogle scholar articles
  • Trevor Williams Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Monash University, Prahran, Victoria, Australia PubMed articlesGoogle scholar articles
  • David Celermajer Department of Cardiology, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Joanne Sahhar Department of Rheumatology, Monash Health and Monash University, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • Peter K K Wong Mid-North Coast Arthritis Clinic, Coffs Harbour, New South Wales, Australia Faculty of Medicine, Rural Clinical School, University of New South Wales, Coffs Harbour, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Vivek Thakkar Department of Rheumatology, Liverpool Hospital, Liverpool, New South Wales, Australia School of Medicine, University of Western Sydney, Penrith, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Nathan Dwyer Department of Cardiology, Royal Hobart Hospital, Hobart, Tasmania, Australia PubMed articlesGoogle scholar articles
  • Jeremy Wrobel Advanced Lung Disease Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Weng Chin Institute for Respiratory Health, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Danny Liew Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Margaret Staples Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia Monash Department of Clinical Epidemiology, Cabrini Institute, Cabrini Health, Suite 41 Cabrini Medical Centre, Malvern, Victoria, Australia PubMed articlesGoogle scholar articles
  • Rachelle Buchbinder Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia Monash Department of Clinical Epidemiology, Cabrini Institute, Cabrini Health, Suite 41 Cabrini Medical Centre, Malvern, Victoria, Australia PubMed articlesGoogle scholar articles
  • Mandana Nikpour Department of Rheumatology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia The University of Melbourne Department of Medicine at St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mandana Nikpour; m.nikpour{at}unimelb.edu.au
View Full Text

Citation

Calderone A, Stevens W, Prior D, et al
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol
BMJ Open 2016;6:e011028. doi: 10.1136/bmjopen-2016-011028

Publication history

  • Received January 1, 2016
  • Revised November 10, 2016
  • Accepted November 14, 2016
  • First published December 8, 2016.
Online issue publication 
October 26, 2017
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/